- 理想的成長型公司, 本業EPS的成長幅度會大於營收的成長幅度
- 營收到某個數字後, 本業EPS呈現不成比例的增加, 有可能是規模經濟的效應
- 如果是有淡旺季的公司, 是否有淡季不淡, 旺季更旺的情況
- 漲很多的股票要留意 EPS 較上季是否有大幅衰退的情況
- 如果EPS衰退，要觀察同業是不是有一樣的狀況
- 要留意增資減資和公司債對股本及EPS的影響
| 加權平均股數 QoQ YoY | EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | 營收 QoQ YoY | 毛利率(%) QoQ YoY | 營業利益率 QoQ YoY | 稅後淨利率 QoQ YoY | 營業利益 QoQ YoY | 稅後淨利 QoQ YoY | 稅前淨利率(%) QoQ YoY | 稅後淨利率(%) QoQ YoY | 兩季平均(YOY)營收成長率(%) | 兩季平均(YOY)EPS成長率(%) | 兩季平均(YOY)本業EPS成長率(%) | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24Q3 (20) | 248 | -0.4 | -0.4 | 1.50 | 42.86 | -0.66 | 1.31 | 65.82 | -13.25 | 3.68 | 68.81 | -0.81 | 15.33 | 11.49 | 6.98 | 62.02 | 5.55 | -5.7 | 29.38 | 42.76 | -16.53 | 26.68 | 34.82 | -2.45 | 4.51 | 59.36 | -10.52 | 3.73 | 42.37 | -0.8 | 32.58 | 28.12 | -7.68 | 26.68 | 34.82 | -2.45 | 9.71 | 17.89 | 26.80 |
| 24Q2 (19) | 249 | 0.0 | 0.0 | 1.05 | -7.08 | -15.32 | 0.79 | -12.22 | -21.78 | 2.18 | 92.92 | -0.91 | 13.75 | 7.93 | 8.95 | 58.76 | -3.16 | -2.39 | 20.58 | -15.41 | -22.25 | 19.79 | -14.48 | -19.91 | 2.83 | -8.71 | -15.27 | 2.62 | -6.76 | -15.21 | 25.43 | -12.01 | -18.44 | 19.79 | -14.48 | -19.91 | -7.31 | 15.36 | -14.45 |
| 24Q1 (18) | 249 | 0.0 | 0.0 | 1.13 | 37.8 | 17.71 | 0.90 | -16.67 | 16.88 | 1.13 | -75.11 | 17.71 | 12.74 | -22.55 | 9.26 | 60.68 | 14.08 | -0.38 | 24.33 | 38.63 | 15.64 | 23.14 | 111.13 | 15.07 | 3.1 | 7.27 | 26.53 | 2.81 | 37.07 | 17.57 | 28.90 | 109.42 | 14.91 | 23.14 | 111.13 | 15.07 | -3.88 | -3.95 | -22.58 |
| 23Q4 (17) | 249 | 0.0 | 0.0 | 0.82 | -45.7 | -16.33 | 1.08 | -28.48 | 17.39 | 4.54 | 22.37 | 3.18 | 16.45 | 14.79 | 7.31 | 53.19 | -19.13 | -1.21 | 17.55 | -50.14 | -14.52 | 10.96 | -59.93 | -29.43 | 2.89 | -42.66 | -8.25 | 2.05 | -45.48 | -16.33 | 13.80 | -60.9 | -36.49 | 10.96 | -59.93 | -29.43 | 14.17 | -11.97 | 10.51 |
| 23Q3 (16) | 249 | 0.0 | 0.0 | 1.51 | 21.77 | 11.03 | 1.51 | 49.5 | 38.53 | 3.71 | 68.64 | 8.48 | 14.33 | 13.55 | 8.07 | 65.77 | 9.25 | 5.15 | 35.20 | 32.98 | 26.48 | 27.35 | 10.68 | 2.43 | 5.04 | 50.9 | 36.59 | 3.76 | 21.68 | 11.24 | 35.29 | 13.18 | 7.1 | 27.35 | 10.68 | 2.43 | 10.89 | 25.47 | 40.34 |
| 23Q2 (15) | 249 | 0.0 | 0.0 | 1.24 | 29.17 | 8.77 | 1.01 | 31.17 | 8.6 | 2.20 | 129.17 | 6.8 | 12.62 | 8.23 | 8.23 | 60.20 | -1.17 | -2.1 | 26.47 | 25.81 | 3.64 | 24.71 | 22.87 | 1.81 | 3.34 | 36.33 | 12.08 | 3.09 | 29.29 | 8.8 | 31.18 | 23.98 | 3.52 | 24.71 | 22.87 | 1.81 | -7.86 | 13.57 | 7.44 |
| 23Q1 (14) | 249 | 0.0 | 0.0 | 0.96 | -2.04 | 5.49 | 0.77 | -16.3 | 2.67 | 0.96 | -78.18 | 5.49 | 11.66 | -23.94 | 12.44 | 60.91 | 13.13 | -2.84 | 21.04 | 2.48 | -11.49 | 20.11 | 29.49 | -8.51 | 2.45 | -22.22 | -0.81 | 2.39 | -2.45 | 4.82 | 25.15 | 15.74 | -9.21 | 20.11 | 29.49 | -8.51 | -4.17 | -14.99 | -15.95 |
| 22Q4 (13) | 249 | 0.0 | 0.0 | 0.98 | -27.94 | -28.99 | 0.92 | -15.6 | -22.69 | 4.40 | 28.65 | 31.34 | 15.33 | 15.61 | 4.43 | 53.84 | -13.92 | -5.92 | 20.53 | -26.23 | -19.99 | 15.53 | -41.84 | -32.71 | 3.15 | -14.63 | -16.45 | 2.45 | -27.51 | -28.78 | 21.73 | -34.05 | -25.02 | 15.53 | -41.84 | -32.71 | 14.66 | -4.32 | 0.80 |
| 22Q3 (12) | 249 | 0.0 | 0.0 | 1.36 | 19.3 | 33.33 | 1.09 | 17.2 | 28.24 | 3.42 | 66.02 | 74.49 | 13.26 | 13.72 | 25.09 | 62.55 | 1.72 | -1.14 | 27.83 | 8.97 | 8.2 | 26.70 | 10.01 | 11.95 | 3.69 | 23.83 | 35.16 | 3.38 | 19.01 | 33.6 | 32.95 | 9.4 | 11.17 | 26.70 | 10.01 | 11.95 | 13.08 | 22.29 | 20.60 |
| 22Q2 (11) | 249 | 0.0 | 0.0 | 1.14 | 25.27 | 776.92 | 0.93 | 24.0 | 10.71 | 2.06 | 126.37 | 116.84 | 11.66 | 12.44 | 11.79 | 61.49 | -1.91 | -1.05 | 25.54 | 7.45 | -2.07 | 24.27 | 10.42 | 773.02 | 2.98 | 20.65 | 9.56 | 2.84 | 24.56 | 787.5 | 30.12 | 8.74 | 232.08 | 24.27 | 10.42 | 773.02 | -8.46 | -4.40 | -6.48 |
| 22Q1 (10) | 249 | 0.0 | 0.0 | 0.91 | -34.06 | 10.98 | 0.75 | -36.97 | 10.29 | 0.91 | -72.84 | 10.98 | 10.37 | -29.36 | 7.57 | 62.69 | 9.54 | -0.71 | 23.77 | -7.37 | 4.58 | 21.98 | -4.77 | 4.97 | 2.47 | -34.48 | 12.79 | 2.28 | -33.72 | 12.32 | 27.70 | -4.42 | 5.52 | 21.98 | -4.77 | 4.97 | 4.57 | 0.61 | 1.52 |
| 21Q4 (9) | 249 | 0.0 | 0.0 | 1.38 | 35.29 | 30.19 | 1.19 | 40.0 | 67.61 | 3.35 | 70.92 | -9.95 | 14.68 | 38.49 | 22.03 | 57.23 | -9.55 | 1.54 | 25.66 | -0.23 | 26.78 | 23.08 | -3.23 | 1.67 | 3.77 | 38.1 | 55.14 | 3.44 | 35.97 | 30.8 | 28.98 | -2.23 | 5.34 | 23.08 | -3.23 | 1.67 | 20.06 | 359.95 | 20.59 |
| 21Q3 (8) | 249 | 0.0 | 0.0 | 1.02 | 684.62 | 14.61 | 0.85 | 1.19 | 70.0 | 1.96 | 106.32 | -26.32 | 10.6 | 1.63 | 3.52 | 63.27 | 1.82 | -0.28 | 25.72 | -1.38 | 21.26 | 23.85 | 757.91 | -7.27 | 2.73 | 0.37 | 25.81 | 2.53 | 690.62 | 13.96 | 29.64 | 226.79 | -4.14 | 23.85 | 757.91 | -7.27 | 4.91 | 300.24 | 12.36 |
| 21Q2 (7) | 249 | 0.0 | 0.0 | 0.13 | -84.15 | -82.67 | 0.84 | 23.53 | 23.53 | 0.95 | 15.85 | -46.33 | 10.43 | 8.2 | 15.76 | 62.14 | -1.58 | -1.74 | 26.08 | 14.74 | 10.41 | 2.78 | -86.72 | -86.31 | 2.72 | 24.2 | 27.7 | 0.32 | -84.24 | -82.8 | 9.07 | -65.45 | -64.51 | 2.78 | -86.72 | -86.31 | -5.84 | -53.40 | 9.65 |
| 21Q1 (6) | 249 | 0.0 | 0.0 | 0.82 | -22.64 | -19.61 | 0.68 | -4.23 | -20.93 | 0.82 | -77.96 | -19.61 | 9.64 | -19.87 | -11.8 | 63.14 | 12.03 | -2.35 | 22.73 | 12.3 | -12.41 | 20.94 | -7.75 | -11.68 | 2.19 | -9.88 | -22.89 | 2.03 | -22.81 | -20.08 | 26.25 | -4.58 | -11.32 | 20.94 | -7.75 | -11.68 | -1.20 | -1.77 | 18.88 |
| 20Q4 (5) | 249 | 0.0 | 0.0 | 1.06 | 19.1 | 715.38 | 0.71 | 42.0 | -7.79 | 3.72 | 39.85 | 2.76 | 12.03 | 17.48 | 8.28 | 56.36 | -11.17 | -12.13 | 20.24 | -4.57 | -7.87 | 22.70 | -11.74 | 1454.79 | 2.43 | 11.98 | -0.41 | 2.63 | 18.47 | 748.39 | 27.51 | -11.03 | 265.34 | 22.70 | -11.74 | 1454.79 | - | - | 0.00 |
| 20Q3 (4) | 249 | 0.0 | 0.0 | 0.89 | 18.67 | 0.0 | 0.50 | -26.47 | 0.0 | 2.66 | 50.28 | 0.0 | 10.24 | 13.65 | 0.0 | 63.45 | 0.33 | 0.0 | 21.21 | -10.2 | 0.0 | 25.72 | 26.7 | 0.0 | 2.17 | 1.88 | 0.0 | 2.22 | 19.35 | 0.0 | 30.92 | 20.97 | 0.0 | 25.72 | 26.7 | 0.0 | - | - | 0.00 |
| 20Q2 (3) | 249 | 0.0 | 0.0 | 0.75 | -26.47 | 0.0 | 0.68 | -20.93 | 0.0 | 1.77 | 73.53 | 0.0 | 9.01 | -17.57 | 0.0 | 63.24 | -2.2 | 0.0 | 23.62 | -8.98 | 0.0 | 20.30 | -14.38 | 0.0 | 2.13 | -25.0 | 0.0 | 1.86 | -26.77 | 0.0 | 25.56 | -13.65 | 0.0 | 20.30 | -14.38 | 0.0 | - | - | 0.00 |
| 20Q1 (2) | 249 | 0.0 | 0.0 | 1.02 | 684.62 | 0.0 | 0.86 | 11.69 | 0.0 | 1.02 | -71.82 | 0.0 | 10.93 | -1.62 | 0.0 | 64.66 | 0.81 | 0.0 | 25.95 | 18.12 | 0.0 | 23.71 | 1523.97 | 0.0 | 2.84 | 16.39 | 0.0 | 2.54 | 719.35 | 0.0 | 29.60 | 293.09 | 0.0 | 23.71 | 1523.97 | 0.0 | - | - | 0.00 |
| 19Q4 (1) | 249 | 0.0 | 0.0 | 0.13 | 0.0 | 0.0 | 0.77 | 0.0 | 0.0 | 3.62 | 0.0 | 0.0 | 11.11 | 0.0 | 0.0 | 64.14 | 0.0 | 0.0 | 21.97 | 0.0 | 0.0 | 1.46 | 0.0 | 0.0 | 2.44 | 0.0 | 0.0 | 0.31 | 0.0 | 0.0 | 7.53 | 0.0 | 0.0 | 1.46 | 0.0 | 0.0 | - | - | 0.00 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/11 | 4.55 | -28.3 | -6.45 | 52.72 | 5.5 | 16.96 | N/A | 0.25 | 5.8 | - |
| 2024/10 | 6.35 | 4.77 | -2.24 | 48.17 | 6.79 | 16.85 | N/A | 0.65 | 5.55 | - |
| 2024/9 | 6.06 | 36.6 | 3.36 | 41.81 | 8.3 | 15.33 | 0.94 | 0.96 | 4.89 | - |
| 2024/8 | 4.44 | -8.22 | 4.72 | 35.75 | 9.18 | 14.01 | 1.03 | 0.41 | 3.94 | - |
| 2024/7 | 4.83 | 2.04 | 14.28 | 31.32 | 9.84 | 14.01 | 1.03 | 0.64 | 3.53 | - |
| 2024/6 | 4.74 | 6.64 | 8.93 | 26.48 | 9.07 | 13.75 | 0.81 | 0.6 | 2.88 | - |
| 2024/5 | 4.44 | -2.73 | -9.25 | 21.75 | 9.1 | 12.99 | 0.86 | 0.53 | 2.28 | - |
| 2024/4 | 4.57 | 14.82 | 35.46 | 17.3 | 15.08 | 11.29 | 0.99 | 0.27 | 1.75 | - |
| 2024/3 | 3.98 | 44.87 | -6.71 | 12.74 | 9.19 | 12.74 | 0.86 | 0.3 | 1.48 | - |
| 2024/2 | 2.75 | -54.34 | -19.22 | 8.76 | 18.36 | 13.59 | 0.8 | 0.2 | 1.18 | - |
| 2024/1 | 6.01 | 24.53 | 50.29 | 6.01 | 50.29 | 15.71 | 0.69 | 0.97 | 0.97 | 因適逢農曆春節連續假期客戶備貨與子公司認列藥證移轉收入所致。 |
| 2023/12 | 4.83 | -0.86 | 12.11 | 54.8 | 8.27 | 16.2 | 0.68 | -0.06 | 5.6 | - |
| 2023/11 | 4.87 | -25.0 | -19.38 | 49.97 | 7.91 | 17.23 | 0.64 | 0.36 | 5.66 | - |
| 2023/10 | 6.5 | 10.78 | 30.47 | 45.1 | 12.01 | 16.59 | 0.66 | 0.51 | 5.31 | - |
| 2023/9 | 5.86 | 38.4 | 10.29 | 38.61 | 9.4 | 14.33 | 0.94 | 1.08 | 5.02 | - |
| 2023/8 | 4.24 | 0.15 | 3.32 | 32.74 | 9.24 | 12.85 | 1.05 | 0.68 | 3.93 | - |
| 2023/7 | 4.23 | -3.44 | 9.96 | 28.51 | 10.18 | 13.51 | 1.0 | 0.49 | 3.25 | - |
| 2023/6 | 4.38 | -10.51 | 16.81 | 24.31 | 10.37 | 12.65 | 0.83 | 0.47 | 2.77 | - |
| 2023/5 | 4.9 | 45.2 | 17.05 | 19.93 | 9.04 | 12.53 | 0.84 | 0.7 | 2.29 | - |
| 2023/4 | 3.37 | -20.92 | -9.44 | 15.03 | 6.67 | 11.03 | 0.95 | 0.41 | 1.59 | - |
| 2023/3 | 4.26 | 25.44 | 16.09 | 11.66 | 12.45 | 11.66 | 0.88 | 0.51 | 1.18 | - |
| 2023/2 | 3.4 | -15.05 | 29.54 | 7.4 | 10.46 | 11.71 | 0.88 | 0.25 | 0.67 | - |
| 2023/1 | 4.0 | -7.1 | -1.81 | 4.0 | -1.81 | 14.35 | 0.72 | 0.42 | 0.42 | - |
| 2022/12 | 4.31 | -28.71 | -8.86 | 50.62 | 11.59 | 15.33 | 0.68 | 0.29 | 5.66 | - |
| 2022/11 | 6.04 | 21.37 | 40.21 | 46.31 | 13.97 | 16.34 | 0.64 | 0.63 | 5.37 | 本月營收包含部份公費流感疫苖銷售及認列「Amphotericin B」微脂體產品權利金收入 |
| 2022/10 | 4.98 | -6.34 | -11.86 | 40.27 | 10.86 | 14.39 | 0.72 | 0.42 | 4.74 | 本月營收包含部分公費流感疫苖銷售 |
| 2022/9 | 5.32 | 29.66 | 36.44 | 35.29 | 15.05 | 13.26 | 0.95 | 0.84 | 4.35 | 本月出貨部分流感疫苖 |
| 2022/8 | 4.1 | 6.58 | 23.59 | 29.97 | 11.93 | 11.69 | 1.08 | 0.53 | 3.51 | - |
| 2022/7 | 3.85 | 2.75 | 13.57 | 25.87 | 10.28 | 11.77 | 1.07 | 0.41 | 2.98 | - |
| 2022/6 | 3.74 | -10.49 | 20.48 | 22.02 | 9.7 | 11.65 | 0.81 | 0.41 | 2.57 | - |
| 2022/5 | 4.18 | 12.32 | 10.41 | 18.28 | 7.72 | 11.58 | 0.82 | 0.52 | 2.16 | - |
| 2022/4 | 3.72 | 1.37 | 5.25 | 14.09 | 6.95 | 10.02 | 0.95 | 0.49 | 1.64 | - |
| 2022/3 | 3.67 | 39.98 | 13.95 | 10.37 | 7.57 | 10.37 | 0.96 | 0.44 | 1.16 | - |
| 2022/2 | 2.62 | -35.62 | 1.34 | 6.7 | 4.37 | 11.43 | 0.87 | 0.25 | 0.72 | - |
| 2022/1 | 4.08 | -13.86 | 6.42 | 4.08 | 6.42 | 13.12 | 0.76 | 0.47 | 0.47 | - |
| 2021/12 | 4.73 | 9.78 | 26.82 | 45.36 | 7.44 | 14.69 | 0.65 | 0.51 | 4.36 | - |
| 2021/11 | 4.31 | -23.7 | 37.61 | 40.63 | 5.56 | 13.85 | 0.69 | 0.45 | 3.85 | 本月營業收入因銷售國內流感疫苗而增加 |
| 2021/10 | 5.65 | 44.99 | 9.34 | 36.32 | 2.72 | 12.86 | 0.74 | 0.74 | 3.4 | 本月及去年同期皆因銷售國內流感疫苗而增加 |
| 2021/9 | 3.9 | 17.45 | -4.65 | 30.67 | 1.59 | 10.6 | 1.19 | 0.59 | 2.67 | - |
| 2021/8 | 3.32 | -2.06 | 9.56 | 26.78 | 2.57 | 9.81 | 1.29 | 0.32 | 2.07 | - |
| 2021/7 | 3.39 | 9.08 | 8.15 | 23.46 | 1.65 | 10.28 | 1.23 | 0.36 | 1.76 | - |
| 2021/6 | 3.1 | -18.03 | 11.66 | 20.07 | 0.62 | 10.43 | 1.02 | 0.43 | 1.4 | - |
| 2021/5 | 3.79 | 7.08 | 41.83 | 16.97 | -1.16 | 10.55 | 1.01 | -0.4 | 0.98 | - |
| 2021/4 | 3.54 | 9.6 | -0.64 | 13.18 | -9.08 | 9.35 | 1.14 | 0.36 | 1.38 | - |
| 2021/3 | 3.23 | 24.66 | -20.84 | 9.64 | -11.83 | 9.64 | 1.08 | 0.36 | 1.02 | - |
| 2021/2 | 2.59 | -32.39 | -16.4 | 6.42 | -5.58 | 10.15 | 1.03 | 0.18 | 0.66 | - |
| 2021/1 | 3.83 | 2.53 | 3.46 | 3.83 | 3.46 | 10.7 | 0.98 | 0.48 | 0.48 | - |
| 2020/12 | 3.73 | 19.22 | 1.63 | 42.22 | -5.46 | 12.03 | 0.92 | 0.3 | 4.49 | - |
| 2020/11 | 3.13 | -39.36 | -16.51 | 38.49 | -6.34 | 12.38 | 0.9 | 0.2 | 4.19 | - |
| 2020/10 | 5.17 | 26.43 | 38.59 | 35.36 | -5.32 | 12.28 | 0.9 | 0.48 | 3.99 | 月營收增加主因為國內流感疫苗銷售增加所致 |
| 2020/9 | 4.09 | 34.97 | 3.92 | 30.19 | -10.19 | 10.24 | 1.16 | 0.75 | 3.5 | - |
| 2020/8 | 3.03 | -3.32 | -23.53 | 26.1 | -12.05 | 8.86 | 1.34 | 0.21 | 2.75 | - |
| 2020/7 | 3.13 | 15.69 | -13.2 | 23.08 | -10.29 | 8.51 | 1.4 | 0.32 | 2.54 | - |
| 2020/6 | 2.71 | 1.34 | -25.74 | 19.87 | -10.15 | 8.94 | 1.2 | 0.21 | 2.19 | - |
| 2020/5 | 2.67 | -24.98 | -27.78 | 17.17 | -7.07 | 10.36 | 1.03 | 0.28 | 1.98 | - |
| 2020/4 | 3.56 | -13.74 | -0.68 | 14.49 | -1.89 | 10.84 | 0.99 | 0.4 | 1.7 | - |
| 2020/3 | 4.13 | 30.74 | 20.88 | 10.98 | -1.83 | 10.98 | 0.75 | 0.55 | 1.32 | - |
| 2020/2 | 3.16 | -14.7 | 11.16 | 6.86 | -11.8 | 10.53 | 0.79 | 0.27 | 0.77 | - |
| 2020/1 | 3.7 | 0.72 | -25.02 | 3.7 | -25.02 | 0.0 | N/A | 0.5 | 0.5 | - |
| 2019/12 | 3.67 | -2.06 | -2.5 | 44.77 | 10.91 | 0.0 | N/A | 0.13 | 5.54 | - |
| 加權平均股數 YoY | EPS YoY | 本業EPS YoY | 營收 YoY | 毛利率(%) YoY | 營業利益率 YoY | 稅後淨利率 YoY | 營業利益 YoY | 稅前淨利 YoY | 稅後淨利 YoY | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | 249 | 0.0 | 4.53 | 2.95 | 4.36 | 18.16 | 55.06 | 8.77 | 59.70 | 0.02 | 24.93 | 2.76 | 20.32 | -6.75 | 13.72 | 11.73 | 14.19 | 0.78 | 11.29 | 3.2 |
| 2022 (9) | 249 | 0.0 | 4.40 | 31.74 | 3.69 | 3.36 | 50.62 | 11.6 | 59.69 | -2.2 | 24.26 | -3.54 | 21.79 | 20.12 | 12.28 | 7.62 | 14.08 | 29.53 | 10.94 | 31.49 |
| 2021 (8) | 249 | 0.0 | 3.34 | -9.97 | 3.57 | 30.29 | 45.36 | 7.44 | 61.03 | -1.09 | 25.15 | 10.89 | 18.14 | -21.74 | 11.41 | 19.23 | 10.87 | -9.57 | 8.32 | -9.96 |
| 2020 (7) | 249 | 0.0 | 3.71 | 2.77 | 2.74 | -26.54 | 42.22 | -5.46 | 61.70 | -5.21 | 22.68 | -17.56 | 23.18 | 14.07 | 9.57 | -22.13 | 12.02 | -0.08 | 9.24 | 2.67 |
| 2019 (6) | 249 | 0.0 | 3.61 | -38.5 | 3.73 | 8.43 | 44.66 | 10.65 | 65.09 | -1.38 | 27.51 | 4.8 | 20.32 | -43.91 | 12.29 | 15.94 | 12.03 | -27.88 | 9.0 | -38.4 |
| 2018 (5) | 249 | 0.0 | 5.87 | 8.7 | 3.44 | -15.27 | 40.36 | -1.05 | 66.00 | 0.78 | 26.25 | -14.83 | 36.23 | 7.99 | 10.6 | -15.67 | 16.68 | 4.58 | 14.61 | 8.62 |
| 2017 (4) | 249 | 0.0 | 5.40 | 12.73 | 4.06 | 17.0 | 40.79 | 8.46 | 65.49 | -3.68 | 30.82 | -1.75 | 33.55 | 0.57 | 12.57 | 6.53 | 15.95 | 5.49 | 13.45 | 12.74 |
| 2016 (3) | 249 | 0.0 | 4.79 | -1.44 | 3.47 | 80.73 | 37.61 | 17.72 | 67.99 | -0.73 | 31.37 | 26.9 | 33.36 | -14.48 | 11.8 | 49.37 | 15.12 | -0.92 | 11.93 | -1.49 |
| 2015 (2) | 249 | 0.0 | 4.86 | 55.27 | 1.92 | 128.57 | 31.95 | 7.21 | 68.49 | 7.88 | 24.72 | 117.8 | 39.01 | 43.21 | 7.9 | 133.73 | 15.26 | 67.69 | 12.11 | 55.26 |
| 2014 (1) | 249 | 6.87 | 3.13 | 24.21 | 0.84 | 127.03 | 29.8 | -4.18 | 63.49 | 0 | 11.35 | 0 | 27.24 | 0 | 3.38 | -0.59 | 9.1 | 8.85 | 7.8 | 32.88 |
